Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025
“Coagulation analyzers market to register a CAGR of 5.7% from 2020 to 2025”
The global coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population. However, the high cost of fully automated coagulation analyzers is estimated to restrain the growth of this market during the forecast period.
“Optical technology segment is expected to grow at the highest rate during the forecast period”
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the coagulation analyzers market is the optical technology. This segment is expected to account for the largest share of the market in 2020.
“Clinical laboratory analyzers segment is estimated to account for the largest share of the coagulation analyzers market in 2020”
Clinical laboratory analyzers are estimated to account for the largest share of the coagulation analyzers market in 2020. The clinical laboratory analyzers market includes systems and consumables. Systems are further classified as automated, semi-automated, and manual systems, while consumables are classified into reagents and standards, controls, and calibrations. The growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities are driving the growth of this market.
“Prothrombin time tests segment is expected to dominate the coagulation analyzers market during the forecast period”
Based on test, the coagulation analyzers market is segmented into prothrombin time (PT/INR) testing, fibrinogen testing, activated partial thromboplastin time testing, D-dimer testing, ACT testing, platelet function tests, anti-factor XA tests, heparin and protamine dose-response tests for ACT, and other coagulation tests. In 2020, the prothrombin time testing segment is estimated to account for the largest share of the coagulation analyzers market. However, the D-dimer tests segment is projected to register the highest CAGR from 2020 to 2025.
“North America is expected to dominate the coagulation analyzers market in 2020”
North America (comprising the US and Canada) is expected to account for the largest share of the global coagulation analyzers market in 2020, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the coagulation analyzers market in North America. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.
Breakdown of supply-side primary interviews, by company type, designation, and region:
Research Coverage
The report provides insights on the following pointers:
The global coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population. However, the high cost of fully automated coagulation analyzers is estimated to restrain the growth of this market during the forecast period.
“Optical technology segment is expected to grow at the highest rate during the forecast period”
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the coagulation analyzers market is the optical technology. This segment is expected to account for the largest share of the market in 2020.
“Clinical laboratory analyzers segment is estimated to account for the largest share of the coagulation analyzers market in 2020”
Clinical laboratory analyzers are estimated to account for the largest share of the coagulation analyzers market in 2020. The clinical laboratory analyzers market includes systems and consumables. Systems are further classified as automated, semi-automated, and manual systems, while consumables are classified into reagents and standards, controls, and calibrations. The growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities are driving the growth of this market.
“Prothrombin time tests segment is expected to dominate the coagulation analyzers market during the forecast period”
Based on test, the coagulation analyzers market is segmented into prothrombin time (PT/INR) testing, fibrinogen testing, activated partial thromboplastin time testing, D-dimer testing, ACT testing, platelet function tests, anti-factor XA tests, heparin and protamine dose-response tests for ACT, and other coagulation tests. In 2020, the prothrombin time testing segment is estimated to account for the largest share of the coagulation analyzers market. However, the D-dimer tests segment is projected to register the highest CAGR from 2020 to 2025.
“North America is expected to dominate the coagulation analyzers market in 2020”
North America (comprising the US and Canada) is expected to account for the largest share of the global coagulation analyzers market in 2020, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the coagulation analyzers market in North America. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
- By Designation: C-level (45%), Director-level (30%), and Others (25%)
- By Region: North America (35%), Europe (30%), Asia Pacific (25%), Latin America (5%), and Middle East & Africa (5%)
Research Coverage
- The report studies the coagulation analyzers market based on test, technology, product, end user, and region
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
- The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total coagulation analyzers market
- The report forecasts the revenue of market segments with respect to five major regions
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the coagulation analyzers offered by the key 18 players in the coagulation analyzers market. The report analyzes the coagulation analyzers market by test, technology, product, end user, and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various coagulation analyzers, their adoption, and type of tests across key geographic regions.
- Market Diversification: Exhaustive information about new product launches & approvals, untapped geographies, recent developments, and investments in the coagulation analyzers market
- Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the coagulation analyzers market along with a competitive leadership mapping of up to 25 players in the market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES MADE
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 COAGULATION ANALYZERS MARKET OVERVIEW
4.2 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT & COUNTRY (2020)
4.3 COAGULATION ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of cardiovascular diseases and
blood disorders
5.2.1.2 Rising geriatric population
5.2.1.3 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 High cost of fully automated coagulation analyzers
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing reagent rental business
5.2.4 CHALLENGES
5.2.4.1 Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches
6 COAGULATION ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CLINICAL LABORATORY ANALYZERS
6.2.1 CONSUMABLES
6.2.1.1 Reagents
6.2.1.1.1 Reagents accounted for the largest share of
the consumables market in 2019
6.2.1.2 Standards, Controls, and Calibrations
6.2.1.2.1 Standards, controls, and calibrations play an important role in ensuring the performance and accuracy of instruments
6.2.2 SYSTEMS
6.2.2.1 Automated systems
6.2.2.1.1 Fully automated systems deliver results with high accuracy and precision in shorter periods
6.2.2.2 Semi-automated systems
6.2.2.2.1 Cost-effectiveness of semi-automated systems to drive their adoption
6.2.2.3 Manual systems
6.2.2.3.1 Manual systems to witness lower growth during
the forecast period
6.3 POINT-OF-CARE TESTING ANALYZERS
6.3.1 POC TESTING ANALYZERS TO WITNESS HIGH DEMAND GROWTH IN
THE COMING YEARS
7 COAGULATION ANALYZERS MARKET, BY TEST
7.1 INTRODUCTION
7.2 PROTHROMBIN TIME TESTING
7.2.1 PT/INR TESTS DOMINATED THE MARKET IN 2019
7.3 D-DIMER TESTING
7.3.1 D-DIMER TESTS ARE USED TO CHECK BLOOD CLOTTING ISSUES
7.4 FIBRINOGEN TESTING
7.4.1 GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO INCREASE
THE DEMAND FOR FIBRINOGEN TESTS
7.5 ACTIVATED CLOTTING TIME TESTING
7.5.1 ACT TESTS HELP HEALTHCARE PROVIDERS TO FIND THE RIGHT DOSAGE
OF HEPARIN
7.6 ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
7.6.1 GROWING NUMBER OF ANGIOPLASTY AND DIALYSIS PROCEDURES TO SUPPORT MARKET GROWTH
7.7 PLATELET FUNCTION TESTS
7.7.1 PLATELET FUNCTION TESTS ARE PERFORMED TO EVALUATE THE ABILITY OF PLATELETS TO CLUMP TOGETHER
7.8 ANTI-FACTOR XA TESTS
7.8.1 ANTI-FACTOR XA TESTS AID IN THE MONITORING OF STANDARD HEPARIN THERAPY FOR UFH
7.9 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
7.9.1 DUE TO LIMITED APPLICATIONS, THIS TEST SEGMENT HAS A VERY SMALL SHARE IN THE COAGULATION ANALYZERS MARKET
7.10 OTHER COAGULATION TESTS
8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 OPTICAL TECHNOLOGY
8.2.1 OPTICAL TECHNOLOGY SEGMENT DOMINATED THE MARKET IN 2019
8.3 MECHANICAL TECHNOLOGY
8.3.1 MECHANICAL ANALYZERS ARE NOT AFFECTED BY ICTERIC OR
LIPEMIC PLASMA
8.4 ELECTROCHEMICAL TECHNOLOGY
8.4.1 INCREASING DEMAND FOR SELF-TESTING TO DRIVE MARKET GROWTH
8.5 OTHER TECHNOLOGIES
9 COAGULATION ANALYZERS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
9.3 CLINICAL LABORATORIES
9.3.1 CLINICAL LABORATORIES FORMED THE LARGEST END-USER SEGMENT IN THIS MARKET
9.4 OTHER END USERS
10 COAGULATION ANALYZERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Favorable research scenario will drive market growth in the US
10.2.2 CANADA
10.2.2.1 Rising demand for blood and blood components to support
market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Increasing incidence of HIV is a major factor driving the growth of
the coagulation analyzers market in Germany
10.3.2 UK
10.3.2.1 Government support to develop innovative diagnostic kits will boost market growth in the UK
10.3.3 FRANCE
10.3.3.1 Presence of proper protocols and guidelines for diagnostics to propel market growth in France
10.3.4 ITALY
10.3.4.1 Increasing preference for coagulation testing during transplantation will result in market growth
10.3.5 SPAIN
10.3.5.1 Consolidation of laboratories in Spain will drive market growth
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Government initiatives and improving healthcare infrastructure to aid market growth
10.4.2 JAPAN
10.4.2.1 Rising POC testing will contribute to market growth in Japan
10.4.3 INDIA
10.4.3.1 High burden of chronic diseases to support market growth
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 DEARTH OF QUALIFIED HEALTHCARE PROFESSIONALS TO RESTRAIN MARKET GROWTH IN LATAM
10.6 MIDDLE EAST & AFRICA
10.6.1 HIGH PREVALENCE OF BLOOD DISORDERS TO SUPPORT MARKET GROWTH IN THE MEA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET RANKING ANALYSIS
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 PRODUCT LAUNCHES AND ENHANCEMENTS
11.4.2 PARTNERSHIPS AND AGREEMENTS
11.4.3 MERGERS & ACQUISITIONS
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view)*
12.1 ABBOTT LABORATORIES
12.2 THERMO FISHER SCIENTIFIC, INC.
12.3 NIHON KOHDEN CORPORATION
12.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
12.5 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
12.6 SYSMEX CORPORATION
12.7 DANAHER CORPORATION
12.8 HORIBA
12.9 DIAGNOSTICA STAGO SAS
12.10 HELENA LABORATORIES CORPORATION
12.11 MACCURA BIOTECHNOLOGY CO., LTD.
12.12 BEIJING SUCCEEDER TECHNOLOGY INC.
12.13 HYCEL HANDELSGES.M.B.H.
12.14 GENRUI BIOTECH INC.
12.15 ERBA DIAGNOSTICS MANNHEIM GMBH (A TRANSASIA BIO-MEDICALS LTD. COMPANY)
12.16 BIO-GROUP MEDICAL SYSTEM
12.17 ROBIMES INDIA PVT. LTD.
12.18 MERIL LIFE SCIENCES PVT. LTD.
*Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES MADE
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 COAGULATION ANALYZERS MARKET OVERVIEW
4.2 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT & COUNTRY (2020)
4.3 COAGULATION ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of cardiovascular diseases and
blood disorders
5.2.1.2 Rising geriatric population
5.2.1.3 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 High cost of fully automated coagulation analyzers
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing reagent rental business
5.2.4 CHALLENGES
5.2.4.1 Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches
6 COAGULATION ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CLINICAL LABORATORY ANALYZERS
6.2.1 CONSUMABLES
6.2.1.1 Reagents
6.2.1.1.1 Reagents accounted for the largest share of
the consumables market in 2019
6.2.1.2 Standards, Controls, and Calibrations
6.2.1.2.1 Standards, controls, and calibrations play an important role in ensuring the performance and accuracy of instruments
6.2.2 SYSTEMS
6.2.2.1 Automated systems
6.2.2.1.1 Fully automated systems deliver results with high accuracy and precision in shorter periods
6.2.2.2 Semi-automated systems
6.2.2.2.1 Cost-effectiveness of semi-automated systems to drive their adoption
6.2.2.3 Manual systems
6.2.2.3.1 Manual systems to witness lower growth during
the forecast period
6.3 POINT-OF-CARE TESTING ANALYZERS
6.3.1 POC TESTING ANALYZERS TO WITNESS HIGH DEMAND GROWTH IN
THE COMING YEARS
7 COAGULATION ANALYZERS MARKET, BY TEST
7.1 INTRODUCTION
7.2 PROTHROMBIN TIME TESTING
7.2.1 PT/INR TESTS DOMINATED THE MARKET IN 2019
7.3 D-DIMER TESTING
7.3.1 D-DIMER TESTS ARE USED TO CHECK BLOOD CLOTTING ISSUES
7.4 FIBRINOGEN TESTING
7.4.1 GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO INCREASE
THE DEMAND FOR FIBRINOGEN TESTS
7.5 ACTIVATED CLOTTING TIME TESTING
7.5.1 ACT TESTS HELP HEALTHCARE PROVIDERS TO FIND THE RIGHT DOSAGE
OF HEPARIN
7.6 ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
7.6.1 GROWING NUMBER OF ANGIOPLASTY AND DIALYSIS PROCEDURES TO SUPPORT MARKET GROWTH
7.7 PLATELET FUNCTION TESTS
7.7.1 PLATELET FUNCTION TESTS ARE PERFORMED TO EVALUATE THE ABILITY OF PLATELETS TO CLUMP TOGETHER
7.8 ANTI-FACTOR XA TESTS
7.8.1 ANTI-FACTOR XA TESTS AID IN THE MONITORING OF STANDARD HEPARIN THERAPY FOR UFH
7.9 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
7.9.1 DUE TO LIMITED APPLICATIONS, THIS TEST SEGMENT HAS A VERY SMALL SHARE IN THE COAGULATION ANALYZERS MARKET
7.10 OTHER COAGULATION TESTS
8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 OPTICAL TECHNOLOGY
8.2.1 OPTICAL TECHNOLOGY SEGMENT DOMINATED THE MARKET IN 2019
8.3 MECHANICAL TECHNOLOGY
8.3.1 MECHANICAL ANALYZERS ARE NOT AFFECTED BY ICTERIC OR
LIPEMIC PLASMA
8.4 ELECTROCHEMICAL TECHNOLOGY
8.4.1 INCREASING DEMAND FOR SELF-TESTING TO DRIVE MARKET GROWTH
8.5 OTHER TECHNOLOGIES
9 COAGULATION ANALYZERS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
9.3 CLINICAL LABORATORIES
9.3.1 CLINICAL LABORATORIES FORMED THE LARGEST END-USER SEGMENT IN THIS MARKET
9.4 OTHER END USERS
10 COAGULATION ANALYZERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Favorable research scenario will drive market growth in the US
10.2.2 CANADA
10.2.2.1 Rising demand for blood and blood components to support
market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Increasing incidence of HIV is a major factor driving the growth of
the coagulation analyzers market in Germany
10.3.2 UK
10.3.2.1 Government support to develop innovative diagnostic kits will boost market growth in the UK
10.3.3 FRANCE
10.3.3.1 Presence of proper protocols and guidelines for diagnostics to propel market growth in France
10.3.4 ITALY
10.3.4.1 Increasing preference for coagulation testing during transplantation will result in market growth
10.3.5 SPAIN
10.3.5.1 Consolidation of laboratories in Spain will drive market growth
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Government initiatives and improving healthcare infrastructure to aid market growth
10.4.2 JAPAN
10.4.2.1 Rising POC testing will contribute to market growth in Japan
10.4.3 INDIA
10.4.3.1 High burden of chronic diseases to support market growth
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 DEARTH OF QUALIFIED HEALTHCARE PROFESSIONALS TO RESTRAIN MARKET GROWTH IN LATAM
10.6 MIDDLE EAST & AFRICA
10.6.1 HIGH PREVALENCE OF BLOOD DISORDERS TO SUPPORT MARKET GROWTH IN THE MEA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET RANKING ANALYSIS
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 PRODUCT LAUNCHES AND ENHANCEMENTS
11.4.2 PARTNERSHIPS AND AGREEMENTS
11.4.3 MERGERS & ACQUISITIONS
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view)*
12.1 ABBOTT LABORATORIES
12.2 THERMO FISHER SCIENTIFIC, INC.
12.3 NIHON KOHDEN CORPORATION
12.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
12.5 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
12.6 SYSMEX CORPORATION
12.7 DANAHER CORPORATION
12.8 HORIBA
12.9 DIAGNOSTICA STAGO SAS
12.10 HELENA LABORATORIES CORPORATION
12.11 MACCURA BIOTECHNOLOGY CO., LTD.
12.12 BEIJING SUCCEEDER TECHNOLOGY INC.
12.13 HYCEL HANDELSGES.M.B.H.
12.14 GENRUI BIOTECH INC.
12.15 ERBA DIAGNOSTICS MANNHEIM GMBH (A TRANSASIA BIO-MEDICALS LTD. COMPANY)
12.16 BIO-GROUP MEDICAL SYSTEM
12.17 ROBIMES INDIA PVT. LTD.
12.18 MERIL LIFE SCIENCES PVT. LTD.
*Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 AND 2050
TABLE 2 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 3 CLINICAL LABORATORY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 CLINICAL LABORATORY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 STANDARDS, CONTROLS, AND CALIBRATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 SEMI-AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 MANUAL SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 POC TESTING ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 16 PROTHROMBIN TIME TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 D-DIMER TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 FIBRINOGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 ACT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 APTT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 PLATELET FUNCTION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 ANTI-FACTOR XA TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 OTHER COAGULATION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 26 OPTICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 MECHANICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 ELECTROCHEMICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 OTHER TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 HOSPITALS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 32 CLINICAL LABORATORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 OTHER END USERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 COAGULATION ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 40 US: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 US: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 42 US: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 43 US: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 44 CANADA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 45 CANADA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 46 CANADA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 47 CANADA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 52 EUROPE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 54 GERMANY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 55 GERMANY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 56 GERMANY: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 57 UK: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 58 UK: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 59 UK: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 60 UK: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 62 FRANCE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 63 FRANCE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 64 FRANCE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 65 ITALY: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 ITALY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 67 ITALY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 68 ITALY: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 70 SPAIN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 71 SPAIN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 72 SPAIN: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 ROE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 ROE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 75 ROE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 76 ROE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 APAC: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 APAC: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 APAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 80 ASIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 81 APAC: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 82 CHINA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 83 CHINA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 84 CHINA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 85 CHINA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 86 JAPAN: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 JAPAN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 88 JAPAN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 INDIA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 INDIA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 92 INDIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 93 INDIA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 95 ROAPAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 96 ROAPAC: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 97 ROAPAC: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 98 LATAM: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 99 LATAM: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 100 LATAM: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 101 LATAM: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 1 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 AND 2050
TABLE 2 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 3 CLINICAL LABORATORY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 CLINICAL LABORATORY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 STANDARDS, CONTROLS, AND CALIBRATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 SEMI-AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 MANUAL SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 POC TESTING ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 16 PROTHROMBIN TIME TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 D-DIMER TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 FIBRINOGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 ACT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 APTT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 PLATELET FUNCTION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 ANTI-FACTOR XA TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 OTHER COAGULATION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 26 OPTICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 MECHANICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 ELECTROCHEMICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 OTHER TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 HOSPITALS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 32 CLINICAL LABORATORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 OTHER END USERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 COAGULATION ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 40 US: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 US: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 42 US: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 43 US: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 44 CANADA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 45 CANADA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 46 CANADA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 47 CANADA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 52 EUROPE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 54 GERMANY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 55 GERMANY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 56 GERMANY: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 57 UK: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 58 UK: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 59 UK: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 60 UK: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 62 FRANCE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 63 FRANCE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 64 FRANCE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 65 ITALY: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 ITALY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 67 ITALY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 68 ITALY: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 70 SPAIN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 71 SPAIN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 72 SPAIN: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 ROE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 ROE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 75 ROE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 76 ROE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 APAC: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 APAC: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 APAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 80 ASIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 81 APAC: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 82 CHINA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 83 CHINA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 84 CHINA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 85 CHINA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 86 JAPAN: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 JAPAN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 88 JAPAN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 INDIA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 INDIA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 92 INDIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 93 INDIA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 95 ROAPAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 96 ROAPAC: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 97 ROAPAC: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 98 LATAM: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 99 LATAM: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 100 LATAM: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 101 LATAM: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
LIST OF FIGURES
FIGURE 1 COAGULATION ANALYZERS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 COAGULATION ANALYZERS MARKET, BY TEST, 2020 VS. 2025 (USD MILLION)
FIGURE 8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 9 COAGULATION ANALYZERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 COAGULATION ANALYZERS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 INCREASING PREVALENCE OF BLOOD DISORDERS TO DRIVE MARKET GROWTH
FIGURE 12 CLINICAL LABORATORY ANALYZERS SEGMENT IS EXPECTED TO ACCOUNT FOR
THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
FIGURE 13 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
FIGURE 14 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
FIGURE 16 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO MARCH 2020
FIGURE 17 COAGULATION ANALYZERS MARKET RANKING ANALYSIS, BY PLAYER, 2019
FIGURE 18 COAGULATION ANALYZERS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 19 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 20 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 21 NIHON KOHDEN: COMPANY SNAPSHOT (2019)
FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
FIGURE 23 SIEMENS HEALTHINEERS GROUP: COMPANY SNAPSHOT (2019)
FIGURE 24 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 1 COAGULATION ANALYZERS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 COAGULATION ANALYZERS MARKET, BY TEST, 2020 VS. 2025 (USD MILLION)
FIGURE 8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 9 COAGULATION ANALYZERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 COAGULATION ANALYZERS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 INCREASING PREVALENCE OF BLOOD DISORDERS TO DRIVE MARKET GROWTH
FIGURE 12 CLINICAL LABORATORY ANALYZERS SEGMENT IS EXPECTED TO ACCOUNT FOR
THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
FIGURE 13 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
FIGURE 14 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
FIGURE 16 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO MARCH 2020
FIGURE 17 COAGULATION ANALYZERS MARKET RANKING ANALYSIS, BY PLAYER, 2019
FIGURE 18 COAGULATION ANALYZERS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 19 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 20 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 21 NIHON KOHDEN: COMPANY SNAPSHOT (2019)
FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
FIGURE 23 SIEMENS HEALTHINEERS GROUP: COMPANY SNAPSHOT (2019)
FIGURE 24 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
